Answer
The hydrochlorothiazide component of Sevikar HCT is associated with an increased risk of non-melanoma skin cancer, including basal cell carcinoma and squamous cell carcinoma, with increasing cumulative exposure, as observed in two epidemiological studies.
Sources for this answer
- Sevikar HCTDaiichi Sankyo UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 17Document updated
Sources checked